10-QFiling Date: Jul 31, 2026
Moderna (MRNA)
mrna-20260630
View SEC Filing
ACC: 0001682852-26-000150
Key Financial MetricsFY2026 · 2026-06-30
Revenue$145.0M
Net Income-$782.0M
Total Assets$10.96B
Stockholders' Equity$6.76B
Operating Cash Flow-$1.16B
keidHome